journal article·2016-10-02Open access

The anticancer effects of biodegradable nanomagnetic dual natural components on the leptin gene expression in lung cancer

Shivadokht Askari, Roya Salehi, Nosratallah Zarghami, Abolfazl Akbarzadeh, Mohammad Rahmati-yamchi

Abstract

Lung cancer is an invasive and progressive, fatal disease with few treatment choices and poor overall survival rates in nonsurgical stages. Leptin (LEP), an adipocyte derivative cytokine, participates in carcinogenesis. Increased amounts of systemic and pulmonary LEP indicate lung cancer. Curcumin (CUR) and silibinin (SIL) are herbal compounds which have many anticancer properties, but they have hydrophobic structures and low solubility in water. In this study, evaluated CUR-SIL dual drug-loaded poly (ɛ-caprolactone) [PCL]-co-poly ethylene glycol (PEG) magnetic nanoparticles (MNPs) were used to determine the inhibitory effect on LEP gene expression. The physicochemical properties of free and CUR-SIL-loaded PCL-PEG were fully characterized. The cytotoxic effect of CUR-SIL-loaded PCL-PEG magnetic nanoparticles was determined by MTT assay. Afterward, the inhibition of LEP gene expression was specified through real-time PCR. Results indicated that CUR-SIL cytotoxicity is time- and dose-dependent. CUR-SIL loaded MNPs showed the IC50 limit in lower concentrations in comparison to net CUR-SIL. CUR-SIL loaded MNPs reduced LEP expression more than net CUR-SIL. These results revealed the possibilities of CUR-SIL-loaded MNPs as a natural and effective antitumor drug delivery system to fight lung tumors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Regulation of Appetite and Obesity · Biochemical Analysis and Sensing Techniques · Adipose Tissue and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Applied Research Center, Tabriz University of Medical Sciences

Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences

Aras International Branch of Tabriz University of Medical Sciences

Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences

References (39)

Show source-provided references
1. Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S. 2012. Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomed. 7:511.
2. Anganeh MT, Mirakabad FST, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al. 2014. The comparison between effects of free curcumin and curcumin loaded PLGA–PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosci. 4:134–145.
3. 10.1155/2013/86395110.1155/2013/863951 ↗
4. 10.7314/APJCP.2014.15.20.893110.7314/APJCP.2014.15.20.8931 ↗
5. Badrzadeh F, Rahmati-Yamchi M, Badrzadeh K, Valizadeh A, Zarghami N, Farkhani SM, et al. 2014. Drug delivery and nanodetection in lung cancer. Artif Cells Nanomed Biotechnol. 11:1–17.
6. 10.2174/157016381131002001010.2174/1570163811310020010 ↗
7. 10.1039/c1jm10631g10.1039/c1jm10631g ↗
8. 10.1002/jcb.2191110.1002/jcb.21911 ↗
9. 10.1038/3291110.1038/32911 ↗
10. Danafar H, Davaran S, Rostamizadeh K, Valizadeh H, Hamidi M. 2014. Biodegradable m-PEG/PCL core–shell micelles: preparation and characterization as a sustained release formulation for curcumin. Adv Pharm Bull. 4:501–510.
11. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA–PEG–Fe3O4 in T47D breast cancer cell line. Bioimpacts 3:67.
12. 10.2147/IJN.S3360710.2147/IJN.S33607 ↗
13. 10.2147/IJN.S2862910.2147/IJN.S28629 ↗
14. 10.1210/endo-118-4-156710.1210/endo-118-4-1567 ↗
15. 10.3349/ymj.2013.54.6.140710.3349/ymj.2013.54.6.1407 ↗
16. 10.1158/1535-7163.MCT-06-055610.1158/1535-7163.MCT-06-0556 ↗
17. 10.1200/JCO.2002.08.04110.1200/JCO.2002.08.041 ↗
18. 10.1016/j.jmhi.2012.10.00510.1016/j.jmhi.2012.10.005 ↗
19. Moorthi C, Kumar CS, Kathiresan K. 2014. Synergistic anti-cancer activity of curcumin and bio-enhancers combination against various cancer cell lines. Int J Pharm Pharm Sci. 6:901–903.
20. Mukerjee A, Vishwanatha JK. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29:3867–3875.
21. 10.7314/APJCP.2013.14.6.344910.7314/APJCP.2013.14.6.3449 ↗
22. 10.7314/APJCP.2013.14.11.659510.7314/APJCP.2013.14.11.6595 ↗
23. 10.1016/j.canlet.2004.01.00810.1016/j.canlet.2004.01.008 ↗
24. Rami A, Zarghami N. 2013. Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull. 3:127.
25. 10.3109/1061186X.2013.87664510.3109/1061186X.2013.876645 ↗
26. 10.1016/j.ijpharm.2015.04.05110.1016/j.ijpharm.2015.04.051 ↗
27. Shen Y, Wang Q, Zhao Q, Zhou J. 2009. Leptin promotes the immune escape of lung cancer by inducing proinflammatory cytokines and resistance to apoptosis. Mol Med Rep. 2:295–299.
28. 10.3322/caac.2120810.3322/caac.21208 ↗
29. 10.1093/jnci/djj23110.1093/jnci/djj231 ↗
30. 10.1016/j.clinbiochem.2013.12.00310.1016/j.clinbiochem.2013.12.003 ↗
31. 10.1016/j.ejpb.2008.09.02610.1016/j.ejpb.2008.09.026 ↗
32. 10.1158/1078-0432.CCR-12-093010.1158/1078-0432.CCR-12-0930 ↗
33. Wu S-H, Hang L-W, Yang J-S, Chen H-Y, Lin H-Y, Chiang J-H, et al. 2010. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways. Anticancer Res. 30:2125–2133.
34. 10.1254/jphs.13085FP10.1254/jphs.13085FP ↗
35. 10.1158/1535-7163.MCT-12-122710.1158/1535-7163.MCT-12-1227 ↗
36. 10.2147/NSA.S3550610.2147/NSA.S35506 ↗
37. 10.1039/c3nr01384g10.1039/c3nr01384g ↗
38. 10.1093/abbs/gmt06310.1093/abbs/gmt063 ↗
39. 10.1016/j.actbio.2007.05.01110.1016/j.actbio.2007.05.011 ↗